TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: apoA1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Knee Replacement (TKR) incidence
Endpoint domain: Mortality/survival
Primary endpoint: Pharmacokinetics of IMU-838
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of IMU-838
Endpoint domain: Adverse events/effects
Primary endpoint: OAHI score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSA-18 score change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: WOMAC-total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: late-phase voluntary RTD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip-/leg-extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to resolution of plugged duct
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: size of mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EZ-RPE volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SHRM volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of excellent outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protrusion percentage decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lesional control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of atrial arrhythmia after ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean maximum increases in CSF cyclic guanosine monophosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: well-tolerated following single and multiple administration
Endpoint domain: Adverse events/effects
Primary endpoint: Preference for laser blepharoplasty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSST score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Lyme borreliosis
Endpoint domain: Adverse events/effects
Primary endpoint: total state-anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: comfort and warmth
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Monocular accommodation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: panretinal MA counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of DC/TMD for TMD-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of probing pocket depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of relative attachment level (RAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma IFN‐γ levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma IL‐6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CDAI score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression levels of TGF‐β 1, Tβ R2, Smad3, and Snail
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean 24h urine calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary citrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Static posturography performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average number of drinks per drinking day (DDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to 17‐hydroxyprogesterone caproate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AUC for detecting csPCa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CR-POPF
Endpoint domain: Adverse events/effects
Primary endpoint: Biochemical fistula rate
Endpoint domain: Adverse events/effects
Primary endpoint: Norepinephrine infusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of intensity of DOMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD gains maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful conversion of AF to normal sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean postoperative heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidental gallbladder carcinoma detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: High-grade dysplasia identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Alcohol Use Disorders Identification Test‐Consumption screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distant Metastasis (DM)
Endpoint domain: Mortality/survival
Primary endpoint: Prostate Cancer-Specific Mortality (PCSM)
Endpoint domain: Mortality/survival
Primary endpoint: Changes in metabolites after spinach intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body shape
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serologic responses at week 9
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in HBV DNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HBV RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of rapid eye movement (REM) sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apnoea hypopnoea index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: number of arousals per hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burden of Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: VPaO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in psychological variables and behaviour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: R0/R1 liver-resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Asthma control (ACQ6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung function (spirometry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of OHPs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitudes of OHPs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-efficacy of OHPs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average pain degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of drain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to fully alert
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vascular outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Appendicular lean mass index change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS Quality of Life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: KOOS Activities of Daily Living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Right ventricular systolic function (M-mode tricuspid annular plane systolic excursion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Unadjusted stroke rates at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Presence or intensity of GI symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Annual exacerbation frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Amount of paracetamol used in the first 24 h postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of tramadol rescue analgesia administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VAS scores at 1, 4, and 12 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average day-long glycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dose length product (DLP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distinction of HER2-negative cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rSO2 (regional cerebral oxygen saturation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SpO2 (oxygen saturation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major erythroid response (MER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Servings of vegetables/fruits (V/F) and dairy products (DP) consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of chest compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to sustained normalization of vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AVF puncture-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fever occurrence after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: deattenuated validity correlation for overall GI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: deattenuated validity correlation for GL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pelvic floor muscle (PFM) strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vaginal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Escherichia coli mortality rates
Endpoint domain: Mortality/survival
Primary endpoint: Amount of bacteria in wound tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Score of wound exudate amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VZV-specific humoral immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: increase in strength in paretic muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence/worsening risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sunset glow fundus grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cataract rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in harsh parenting practices
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Acceptability of eB2 app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Abdominal pain responder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher Gleason score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Average score on the scale of the general severity of ARVI manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of systemic and local manifestations of acute respiratory viral infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription of additional therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Resting MSNA burst frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurovascular transduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GPE scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sustained attention response time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mindfulness attention awareness score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: work stress score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: personal distress related to ejaculation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: interpersonal difficulty related to ejaculation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: satisfaction with sexual intercourse
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: changes in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum creatine kinase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suspected influenza outbreaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: laboratory-confirmed influenza outbreaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Physical well-being score (PWB)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of neuropsychiatric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gastrointestinal issues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: children's fundamental movement skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adenoma detection rate (APC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total number of non-neoplastic lesions resected (THR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Experience of DBSH behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: satisfaction using the CRP
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of significant CRCI
Endpoint domain: Adverse events/effects
Primary endpoint: TEAR responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of Virologic Failure (VF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Color deterioration of Figaro crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective image quality assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D printing model evaluation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-Related Quality of Life (HRQOL) in Role/social component
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Health-Related Quality of Life (HRQOL) in Mental component
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Working Memory Index (WMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grade 3+ adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Directly measured free 25‐hydroxyvitamin D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clearance of anifrolumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total sign and symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virus-neutralizing titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local reactions and systemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Intervention usefulness rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Psychomotor speed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: S-CTX levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: S-iPINP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: Plasma parathyroid hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Imaging costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: nephrology referral rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no residual fragments >2 mm at unenhanced CT scan at 3 months postop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no complications (defined as Clavien‐Dindo Score 0)
Endpoint domain: Adverse events/effects
Primary endpoint: operation carried out without placing a nephrostomy tube (tubeless or totally tubeless)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Completion of required intervention visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acute grade ≥3 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Loco-regional control rates at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of subjective shame
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Levels of negative emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Levels of maladaptive coping strategies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: biochemical measures (CRP, TNF‐α, IL‐2, IL‐4, IL‐6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VAS score in a state of static
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score in the state of flexion and extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of PI-RADS for Gleason score ≥3 + 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of PI-RADS for Gleason score ≥3 + 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmission or death
Endpoint domain: Mortality/survival
Primary endpoint: ∆E
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Packed Cell Volume (PCV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total Plasma Protein Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Length of stay (LOS) ≥3 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: oesophageal pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total frailty index (FI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depression and anxiety component of FI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PaO2 (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of spontaneous breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: intent to use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Housing stability as an adult
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Diagnostic accuracy of caries detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of false positives in caries detection
Endpoint domain: Adverse events/effects
Primary endpoint: Sight-threatening diabetic retinopathy detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Attendance rates at first follow-up
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Incremental cost savings per person
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: rate of anastomotic leakage
Endpoint domain: Adverse events/effects
Primary endpoint: apoA-I plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total CEC and ABCA1-mediated CEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total test time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of stress during biomechanical preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of caesarean deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes